Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Columbia Select Large Cap Growth Fund

+ Add to Watchlist

CSRRX:US

19.68 USD 0.14 0.72%

As of 09:29:30 ET on 03/02/2015.

Snapshot for Columbia Select Large Cap Growth Fund (CSRRX)

Year To Date: +8.19% 3-Month: +6.81% 3-Year: - 52-Week Range: 15.68 - 19.71
1-Month: +8.55% 1-Year: +10.02% 5-Year: - Beta vs RLG: 1.14

Mutual Fund Chart for CSRRX

No chart data available.
  • CSRRX:US 19.68
  • 1M
  • 1Y
Interactive CSRRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CSRRX

Columbia Select Large Cap Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is superior, long-term capital appreciation. The Fund invests at least 80% of its net assets in common stocks of large U.S. companies that have market capitalizations of companies included in the Russell 1000 Growth Index.

Inception Date: 11-09-2012 Telephone: 1-800-345-6611
Managers: THOMAS M GALVIN / RICHARD A CARTER
Web Site: www.columbiafunds.com

Fundamentals for CSRRX

NAV (on 2015-03-02) 19.68
Assets (M) (on 2015-03-02) 7,357.09
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for CSRRX

No dividends reported

Fees & Expenses for CSRRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee -
12b1 Fee 0.00
Expense Ratio 0.85

Top Fund Holdings for CSRRX

Filing Date: 01/30/2015
Name Position Value % of Total
Pharmacyclics Inc 1,991,397 336,048,244 4.942%
Amazon.com Inc 879,098 311,666,614 4.583%
LinkedIn Corp 1,362,056 306,108,465 4.501%
Biogen Idec Inc 765,452 297,883,300 4.380%
Priceline Group Inc/The 291,427 294,189,728 4.326%
Illumina Inc 1,477,873 288,466,031 4.242%
Celgene Corp 2,338,942 278,708,329 4.098%
Visa Inc 975,094 248,561,212 3.655%
Vertex Pharmaceuticals Inc 2,227,395 245,325,285 3.608%
Bristol-Myers Squibb Co 4,051,733 244,197,948 3.591%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil